STAT Plus: Illumina earnings points to worrying signs for consumer genetics industry

If you look closely at Thursday’s bad news from Illumina, the multibillion-dollar standard-bearer of the genomics industry, you might see a worrisome sign for the consumer genetics industry.

Click to view original post